Aprogen Bio CB terms amended, higher dilution
에이프로젠
007460
Signal Score
Historical Avg Return (5d)
+0.33%
Data Coverage
100%n=2377
Risk-adjusted indicator based on 2377 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • New Conversion Price: 2,353 KRW/Share (Previously 3,778 KRW/Share)
- • Shares Issued upon Conversion: 21,589,460 Shares (Previously 13,446,267 Shares)
- • Dilution Rate: 149.80% (Previously 90.30%)
- • Total Convertible Shares (including existing CBs): 46,016,552 Shares
- • Total Dilution Rate (including existing CBs): 319.29%
AI Analysis Summary
Aprogen Bio amended its convertible bond terms, significantly lowering the conversion price from 3,778 KRW to 2,353 KRW per share. This change increases the potential shares issued upon conversion from 13,446,267 to 21,589,460, raising the dilution rate from 90.30% to 149.80% relative to current outstanding shares. Including existing convertible bonds, the total potential dilution reaches 319.29%. The bonds, totaling 50.8 billion KRW, are for debt repayment to affiliates. This substantial increase in potential dilution is a negative for existing shareholders.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.